Patent ID: 9642824
Date: 2017-05-09
CPC Classifications: A61K,A61P

Claim:
1. A method to treat a subject who is infected with herpes simplex virus type 1 and who is afflicted with one or more functional somatic syndrome conditions, the method comprising administering to the subject a therapeutically-effective combination of valacyclovir and diclofenac, wherein the amount of valacyclovir is administered in a total daily dose range from about 750 mg to about 2000 mg, and wherein the amount of diclofenac is administered in a total daily dose range from about 100 mg to about 150 mg, wherein the one or more functional somatic syndrome condition is selected from the group consisting of fibromyalgia, chronic fatigue syndrome, irritable bowel syndrome, chronic depression, chronic clinical anxiety disorder and chronic interstitial cystitis.